| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8454482 | Lung Cancer | 2016 | 6 Pages | 
Abstract
												The prevalence of RET fusion is approximately 1.8% in Chinese patients with lung adenocarcinoma. RET rearrangements are characterized by lepidic predominance and a lower TS level. RET-rearranged patients may benefit more from pemetrexed-based regimen.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Zhengbo MD, Xinmin Yu, Yiping MD, 
											